NanoViricides Inc (NNVC)
US$ 1.44-3.36%
Price Chart
Key Statistics
Market Cap
$ 21.54M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
114.1K
52W High
$ 2.55
52W Low
$ 0.94
Dividend Yield
0.00%
Beta
0.92
Technicals
50-Day MA
1.3894
200-Day MA
1.3837
52 Week High
2.55
52 Week Low
0.94
About NNVC
NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections.
Employees
7
Headquarters
Shelton, CT
CEO
Dr. Anil R. Diwan Ph.D.
Latest News
NanoViricides touts antiviral NV-387 as tool against new COVID variant - Proactive Investors
17 hours ago • Google News
NanoViricides Inc. (NNVC): Best Nanotech Penny Stock to Buy - Yahoo Finance
2024-10-14 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg